Nathan Peiffer‐Smadja

Type 1 interferons as a potential treatment against COVID-19

Erwan Sallard, François-Xavier Lescure, Yazdan Yazdanpanah et al. · Antiviral Research · 2020 · 549 citations · Full text

Covid-19 Pandemic, Immunology, Antiviral Therapy +4

Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial

Florence Ader, Maude Bouscambert‐Duchamp, Maya Hites et al. · The Lancet Infectious Diseases · 2021 · 338 citations · Full text

Clinical characteristics of ambulatory and hospitalized patients with monkeypox virus infection: an observational cohort study

Morgane Mailhé, Anne‐Lise Beaumont, Michaël Thy et al. · Clinical Microbiology and Infection · 2022 · 185 citations · Full text

Clinical Characteristics, Clinical Epidemiology, Healthcare-associated Infection +9

Neurologic manifestations associated with COVID-19: a multicentre registry

Elodie Meppiel, Nathan Peiffer‐Smadja, T. de Broucker · Clinical Microbiology and Infection · 2020 · 139 citations · Full text

Neuroinfectious Diseases, Neurologic Manifestations, Covid-19 Pandemic +4

Performance and impact of a multiplex PCR in ICU patients with ventilator-associated pneumonia or ventilated hospital-acquired pneumonia

Nathan Peiffer‐Smadja, Lila Bouadma, Vincent Mathy et al. · Critical Care · 2020 · 126 citations · Full text